Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas

NCT04288726 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Classical Hodgkin Lymphoma

Interventions

BIOLOGICAL: CD30.CAR-EBVST cells

Sponsor

Baylor College of Medicine

Collaborators

[object Object]